What is Neonatal Genetic Testing of Hearing Impairment:
Hearing impairment is the partial or total inability to hear. The incident rate of newborns suffering from hearing impairment is about three in every thousand newborns. More than half of the congenital and acquired hearing impairment cases showed strong genetic involvement. Early detection of the hearing impairment allows early intervention and good quality of treatment management with early support, significantly reducing the difficulties of children language and social development at a later stage. Therefore, it is important to identify the genetic mutations causing hearing impairment in the newborns as soon as possible.Services:
Neonatal genetic testing for hearing impairment exploits the Matrix-Assisted Laser Desorption/ Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) to examine tiny trace of genomic DNA from a droplet of peripheral dry blood spot. 4 genes known to cause inherited hearing loss are analyzed, including the gene resulting in aminoglycoside induced-hearing loss (12S rRNA) and Pendred Syndrome (SLC26A4).Advantages:
